Panacea Biotech Stock: This small-cap pharma company’s shares surge near 120% in 3 months – check what analyst says
The shares of Panacea Biotec surged near nine per cent to Rs 411 per share on the BSE intraday trade today, as the company gets DGCI approval to manufacture Sputnik V Covid-19 vaccine.
At around 12:40 pm, the stock is trading over five and a half per cent higher: PTI